1. Home
  2. FGEN vs CMBM Comparison

FGEN vs CMBM Comparison

Compare FGEN & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • CMBM
  • Stock Information
  • Founded
  • FGEN 1993
  • CMBM 2011
  • Country
  • FGEN United States
  • CMBM United States
  • Employees
  • FGEN N/A
  • CMBM N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • FGEN Health Care
  • CMBM Technology
  • Exchange
  • FGEN Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • FGEN 34.5M
  • CMBM 39.5M
  • IPO Year
  • FGEN 2014
  • CMBM 2019
  • Fundamental
  • Price
  • FGEN $0.46
  • CMBM $1.35
  • Analyst Decision
  • FGEN
  • CMBM Strong Buy
  • Analyst Count
  • FGEN 0
  • CMBM 3
  • Target Price
  • FGEN N/A
  • CMBM $5.50
  • AVG Volume (30 Days)
  • FGEN 727.9K
  • CMBM 204.7K
  • Earning Date
  • FGEN 02-24-2025
  • CMBM 02-18-2025
  • Dividend Yield
  • FGEN N/A
  • CMBM N/A
  • EPS Growth
  • FGEN N/A
  • CMBM N/A
  • EPS
  • FGEN N/A
  • CMBM N/A
  • Revenue
  • FGEN $180,015,000.00
  • CMBM $172,215,000.00
  • Revenue This Year
  • FGEN $21.91
  • CMBM N/A
  • Revenue Next Year
  • FGEN N/A
  • CMBM $16.49
  • P/E Ratio
  • FGEN N/A
  • CMBM N/A
  • Revenue Growth
  • FGEN 16.15
  • CMBM N/A
  • 52 Week Low
  • FGEN $0.18
  • CMBM $0.64
  • 52 Week High
  • FGEN $2.80
  • CMBM $4.92
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 41.72
  • CMBM 59.95
  • Support Level
  • FGEN $0.46
  • CMBM $1.11
  • Resistance Level
  • FGEN $0.51
  • CMBM $1.69
  • Average True Range (ATR)
  • FGEN 0.04
  • CMBM 0.14
  • MACD
  • FGEN -0.01
  • CMBM 0.02
  • Stochastic Oscillator
  • FGEN 6.59
  • CMBM 43.71

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: